AzTrials
AzTrials

PrematurityPremalocom2NCT06027645

Early Intervention Based on Neonatal Crawling in Very Premature Infants at Risk For Neurodevelopmental Disorder

A study testing Crawling stimulation with a mini-skateboard (i.e. the crawliskate) in people with Prematurity and Extreme Prematurity, run by Marianne Barbu-Roth at 3 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Extreme prematurity is constantly increasing according to the World Health Organization. However, methods to train premature infants at risk of disability is sorely lacking. The goal of this project is to overcome this problem. Read more about this study

Who is it for?
Ages 39 to 42 weeks
What is being tested?
Crawling stimulation with a mini-skateboard (i.e. the crawliskate)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
3 sitesFrance
Study dates
29 Mar 2021to 31 Dec 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 39 to 42 weeks
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Term between 24-26 GA or 26-32 GA with suspected brain lesion
  • parental consent
  • family living in intervention area
  • good tolerance on the first crawliskate trial

Who cannot join

  • no bronchodysplasia defined by oxygen dependency after 36 GA
  • no medical disease
  • no limb deformity
  • no karyotype anomaly
  • no visual or auditory impairment

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Marianne Barbu-Roth, PhD contact

00336 18 61 09 15

barburoth@gmail.com

Elodie Hinnekens, PT, PhD contact

00336 31 75 24 20

elodie.hinnekens@gmail.com

France3 sites, 3 recruiting
  • Hôpital Paris Saint-Joseph

    Paris, 75014

    Laurence Boujenah, MD, lboujenah@ghpsj.fr

    Recruiting
  • Cnrs Umr 8002

    Paris, Île-de-France Region, 75006

    Marianne Barbu-Roth, PhD, 0033618610915, barburoth@gmail.com

    Elodie Hinnekens, PT, PhD, 0033631752420, elodie.hinnekens@gmail.com

    Recruiting
  • Hôpital Robert Debré

    Paris, Île-de-France Region, 75019

    Valérie Biran, MD, PhD, 00336 88 48 48 85, valerie.biran@aphp.fr

    Recruiting

Other trials in France

About this study

Official title: Effects of Early Crawling Training Via a Mini-Skateboard on the Motor Development of Very Premature Infants at Risk For Neurodevelopmental Disorder

Extreme prematurity is constantly increasing according to the World Health Organization. However, methods to train premature infants at risk of disability is sorely lacking. The goal of this project is to overcome this problem. In previous studies, the investigators discovered that promoting the crawling of typical newborns on a mini skateboard, the Crawliskate (a new tool that the investigators designed and patented EP2974624A1), is an excellent way to stimulate infants' motor and locomotor development. This method is a promising way to provide early interventions in infants at heightened risk for developmental delay, such as premature infants.

The specific objective of this study is to determine if early training in crawling on this mini skateboard will accelerate motor (particularly locomotor) and/or neuropsychological development in very premature infants identified as high risk for developmental delay.

Read more

Methodology: The investigators will study and follow two groups of very premature infants born between 24 and 26 weeks of gestational age or born between 26 and 32 with major brain lesions.

These infants will be recruited before their hospital discharge at the NICU. After their discharge from the hospital, one group of infants will be trained at home by their parents under the supervision of physiotherapists to crawl on the Crawliskate every day for 2 months (Crawli group), and one group of infants will receive regular medical care (Control group). All infants will be tested for: 1)their crawling proficiency on the Crawliskate at term-equivalent age (just before training for the trained groups) and at 2 and 6 months corrected age (CA, i.e., age determined from the date on which they should have been born), 2) their motor proficiency between 2 and 12 months CA (2D and 3D recording of head control, sitting, crawling, stepping, walking) and 3) their neurodevelopmental, motor and neuropsychological development between 0 and 28 months CA: BSID III edition, ASQ-3, Amiel-Tison's Neurological Assessment, Prechtl Assessment of general movements. One more ASQ-3 questionnaire will be provided at five years.

Expected results: The first research hypothesis is that premature infants trained daily to crawl (for two months after discharge from the NICU) will acquire proficient crawling patterns and develop earlier and more effective motor and neuropsychological development than premature infants who receive no training.

Being tested
Crawling stimulation with a mini-skateboard (i.e. the crawliskate)
Keywords
Prematurity, Crawling, Early intervention, Motor development, Locomotion
Medical subject headings
Premature Birth, Brain Injuries, Learning Disabilities

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Crawling stimulation with a mini-skateboard (i.e. the crawliskate)Behavioural

    Consists of 8 weeks of daily training. Infants benefit from a 10 minutes session everyday at home with either a trained therapist or his/her parents. Parents are trained by the therapist at the begining of the 8 weeks. During each session the infant is prone wrapped on a mini-skateboard (i.e. the crawliskate) and has to produce flexion and extension movements with his four limbs in order to move forward with the assistance of the adult (therapist or parent).

Study groups in NCT06027645
Study groupRoleWhat they receive
Crawli GroupExperimentalParticipants from the Crawli Group will benefit from the crawling stimulation intervention with a mini-skateboard (i.e. the crawliskate) in addition to usual care
Receives: Behavioral: Crawling stimulation with a mini-skateboard (i.e. the crawliskate)
Control GroupNo interventionControl group infants benefit from usual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gross motor score from the Bayley Scale of Infant and toddlers Development III ed.

    The Bayley Scale of Infant and toddlers Development III ed. (BSID III) assesses several aspect of development: motor, fine motor, communication, personal social, language and problem solving domain.

    A score can be obtained for each aspect. At 12 months corrected age we only evaluate gross and fine motor scores, and we consider the gross motor score obtained at 12 months corrected age as the primary outcome of our study.

    The minimal score is 0 and there is no maximal score (the child is asked to complete several tasks, and the test can continues with questions from an upper age and only stops when a child no longer succeed with the tasks to complete). A higher score means more advanced skills.

    Measured: 12 months corrected age

Secondary outcomes (5)
  1. Amiel-Tison Neurological Assessment

    Infant neurological examination at study entry and after the training

    Measured: at 39-42 gestational age, 2, 9, 12 months corrected age

  2. Prechtl assessment

    General movements assessment by video recording: measures the fluency and variability of spontaneous movement while the infant is lying supine on a mattress

    Measured: at 39-42 gestational age and 2 months corrected age

  3. Age and Stage questionnaire (ASQ) 3

    Parental appreciation of their infant development in personal-social, communication, gross motor, fine motor and problem solving domain The minimal score is 0 and the maximal score is 60. A higher score means more advanced skills.

    Measured: 2, 6, 9, 12, 18, 28 corrected age and 5 years

  4. 2D & 3D analysis of movement

    2D \& 3D analysis of movement (head control, sitting, crawling, stepping, walking) using a motion capture system.

    Measured: at 39-42 gestational age, 2, 6, 9, 12 months corrected age

  5. Fine and gross motor scores from the Bayley Scale of Infant and toddlers development III ed.

    The Bayley Scale of Infant and toddlers Development III ed. (BSID III) assesses several aspect of development: motor, fine motor, communication, personal social, language and problem solving domain.

    A score can be obtained for each aspect. At 2, 6, 9, 12 and 24 months corrected age we only evaluate fine and gross motor scores. Note that the gross motor score obtained at 12 months corrected age is the primary outcome of our study but the fine motor score obtained at 12 months corrected age is also a secondary outcome.

    The minimal score is 0 and there is no maximal score (the child is asked to complete several tasks, and the test can continues with questions from an upper age and only stops when a child no longer succeed with the tasks to complete). A higher score means more advanced skills.

    Measured: 2, 6, 9, 12, 24 months corrected age

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Sep 2023
  2. Study start29 Mar 2021
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion31 Dec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06027645
Sponsor's protocol ID
Premalocom2
Acronym
Premalocom2
Status last verified
Sep 2023
First submitted
31 Aug 2023
Last updated
13 Sep 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: IPD will be made available upon reasonable request to corresponding author

Questions about this trial

What is this clinical trial studying?

A study testing Crawling stimulation with a mini-skateboard (i.e. the crawliskate) in people with Prematurity and Extreme Prematurity, run by Marianne Barbu-Roth at 3 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Marianne Barbu-Roth, PhD (00336 18 61 09 15, barburoth@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gross motor score from the Bayley Scale of Infant and toddlers Development III ed. (time frame: 12 months corrected age). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in